MedTrace Logo

Clinical Trials of Two Helichrysum Infusions in Adults

NCT04866628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-09-29

No results posted yet for this study

Summary

The study evaluates the effects of Helichrysum italicum and Helichrysum Arenarium on different components of the metabolic syndrome. The components of metabolic syndrome will be measured at baseline and four weeks after daily consumptions of either Helichrysum italicum or either Helichrysum Arenarium, and after two weeks of washout. In addition, stool samples will be also taken at baseline and after four weeks of daily consumtion of either Helichrysum italicum or either Helichrysum Arenarium.

Conditions

Interventions

DIETARY_SUPPLEMENT

Helichrysum italicum infusion

Comparison of metabolic syndrome components before and after four weeks of daily consumption of Helichrysum italicum infusion.

DIETARY_SUPPLEMENT

Helichrysum arenarium

Comparison of metabolic syndrome components before and after four weeks of daily consumption of Helichrysum arenarium infusion.

Sponsors & Collaborators

  • University of Primorska

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2021-06-03
Completion
2021-06-19

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04866628 on ClinicalTrials.gov